Welcome to our dedicated page for Exponent news (Ticker: EXPO), a resource for investors and traders seeking the latest updates and insights on Exponent stock.
Exponent Inc. (Nasdaq: EXPO) is a leading engineering and scientific consulting firm dedicated to providing solutions to complex issues faced by various industries. The company operates through a highly multidisciplinary organization comprising scientists, physicians, engineers, and business consultants, bringing together over 90 technical disciplines. With a presence in 20 offices across the United States and 6 international locations, Exponent is committed to delivering unparalleled technical expertise.
Core Business and Services: Exponent operates through two main segments: Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment, which accounts for the majority of Exponent's revenue, focuses on services such as biomechanics, biomedical engineering, civil engineering, and construction consulting. The Environmental and Health segment addresses chemical regulation, food safety, ecological and biological sciences, and environmental and earth sciences.
Latest Achievements: Exponent recently reported a 5% increase in total revenues for the third quarter of 2023, highlighting its adaptability and diversified portfolio. The company also announced a quarterly cash dividend of $0.26 per share to be paid in December 2023 and has continued its commitment to return value to shareholders through dividends and stock repurchases.
Recent Projects: The firm is actively engaged in failure analysis and dispute-related work across multiple sectors, including consumer electronics, transportation, and energy. It has also been involved in regulatory consulting services for the chemical industry and in providing safety-related evaluations.
Financial Condition: Exponent's financial results for the first three quarters of 2023 include a 7% increase in total revenues to $413.9 million. The company closed the period with $137.1 million in cash and cash equivalents, indicating robust financial health.
Partnerships and Collaborations: Exponent collaborates with a wide range of clients, including multinational corporations, startups, law firms, insurance companies, and government agencies. This diverse client base underscores the firm's ability to address a variety of complex challenges.
In summary, Exponent Inc. continues to leverage its deep technical expertise and multidisciplinary approach to address the evolving needs of modern industries, ensuring long-term growth and value creation for its stakeholders.
Exponent, Inc. (Nasdaq: EXPO) announced that Dr. Catherine Corrigan and Richard Schlenker will present at the Berenberg US CEO Conference.
The conference is scheduled for Tuesday, November 9, 2021, from 12:00 PM to 12:45 PM PT. A webcast of the presentation will be available on the investor relations section of the Exponent website, with an archived replay accessible post-event.
Exponent provides engineering and scientific consulting solutions, leveraging over 50 years of experience in analyzing complex challenges.
Exponent, Inc. (Nasdaq:EXPO) has declared a quarterly cash dividend of $0.20 per share, payable on December 17, 2021, to shareholders of record as of December 3, 2021. The company plans to continue quarterly dividends each year in March, June, September, and December, contingent on Board approval. CEO Dr. Catherine Corrigan highlighted the company’s strong cash flow and balance sheet, affirming their commitment to high-quality data analytics and long-term shareholder value.
Exponent, Inc. (Nasdaq: EXPO) reported a solid third quarter for fiscal year 2021, with net revenues increasing by 16% to $116.4 million and net income rising to $24.6 million or $0.46 per diluted share. EBITDA improved to $34 million, representing 31.4% of net revenues. The company anticipates mid-single digit revenue growth for Q4 and a decrease in EBITDA margins between 175 to 225 basis points.
Overall, Exponent remains focused on expanding its multidisciplinary services amid growing demand and aims for profitable growth across various sectors.
Exponent, Inc. (Nasdaq: EXPO) will announce its third-quarter fiscal 2021 financial results on October 28, 2021, after market close. CEO Dr. Catherine Corrigan and CFO Richard Schlenker will lead a conference call at 4:30 p.m. ET to discuss the results. Interested parties can access the call via phone or through the company's Investor Relations webpage, where an archived version will also be available later. The firm specializes in engineering and scientific consulting, leveraging decades of expertise to solve complex problems for clients.
Exponent Inc. (Nasdaq: EXPO) has declared a quarterly cash dividend of $0.20 per share, payable on September 24, 2021, to stockholders of record as of September 10, 2021. This decision reflects the company’s strong balance sheet and business resilience. Exponent aims to continue its quarterly dividend payouts in March, June, September, and December. CEO Dr. Catherine Corrigan highlighted the firm’s commitment to delivering valuable solutions to complex challenges, ensuring long-term shareholder value.
Exponent, Inc. (Nasdaq: EXPO) reported strong Q2 2021 results, with net revenue up 30% to $119.9 million, driven by robust demand post-pandemic. EBITDA margin expanded 630 basis points year-over-year, reaching 32.3% of net revenues. Net income increased to $25.4 million, or $0.48 per diluted share, compared to $16.3 million in Q2 2020. The company maintains a positive outlook for the remainder of the year, expecting low-double digit revenue growth and increased EBITDA margins. Exponent reported $240 million in cash and repurchased $7 million of stock.
Exponent, Inc. (EXPO) will report its Q2 fiscal year 2021 financial results on July 29, 2021, after market close. Dr. Catherine Corrigan, CEO, and Richard Schlenker, CFO, will host a conference call at 4:30 p.m. ET to discuss the results. The call will be accessible via a live and archived webcast on the company's Investor Relations website. A telephonic replay will be available until August 5, 2021. Exponent specializes in engineering and scientific consulting, leveraging over 50 years of experience in solving complex problems across various technical disciplines.
Exponent, Inc. (NASDAQ: EXPO) announced the appointment of John Doyle, Dr.P.H., as Group Vice President, Health Sciences on May 17, 2021. Dr. Doyle will lead the company's Health Sciences team, addressing environmental, occupational, medical, and public health challenges. CEO Dr. Catherine Corrigan highlighted Dr. Doyle's experience in healthcare research and the pharmaceutical sector, aiming to drive growth in life sciences. Dr. Doyle has authored over 200 research articles, primarily in oncology, and holds advanced degrees in Epidemiology from Columbia University.
Exponent, Inc. (Nasdaq:EXPO) announced that CEO Dr. Catherine Corrigan and CFO Richard Schlenker will present at the Berenberg Conference USA 2021 on May 18, 2021, at 11:00 AM PT. Investors can access a live webcast of this presentation on Exponent's investor relations website, with an archived replay available afterward. Exponent is known for its engineering and scientific consulting, leveraging over 50 years of experience to tackle complex challenges across various sectors.
Exponent, Inc. (Nasdaq:EXPO) declared a quarterly cash dividend of $0.20 per share, to be paid on June 25, 2021, to stockholders of record as of June 11, 2021. The company has consistently increased dividends, marking the eighth consecutive year of growth, reflecting its strong balance sheet and commitment to long-term shareholder value. Exponent plans to continue quarterly dividends in March, June, September, and December, contingent upon Board approval.
FAQ
What is the current stock price of Exponent (EXPO)?
What is the market cap of Exponent (EXPO)?
What services does Exponent Inc. offer?
What are Exponent's main business segments?
How has Exponent performed financially recently?
Where is Exponent Inc. located?
Who are Exponent's clients?
What recent projects has Exponent been involved in?
What recent achievements has Exponent announced?
What is Exponent's approach to problem-solving?
How can I contact Exponent Inc.?
What is Exponent's outlook for the future?
